Results 141 to 150 of about 655,437 (260)

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

open access: yesMolecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti   +3 more
wiley   +1 more source

Six-minute walk distance in healthy subjects: reference standards from a general population sample. [PDF]

open access: yesRespir Res, 2022
Cazzoletti L   +9 more
europepmc   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

open access: yesMolecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken   +7 more
wiley   +1 more source

Standard Reference Materials

open access: yes, 1986
K L Eckerle   +4 more
openaire   +2 more sources

Physical fitness reference standards for Chinese children and adolescents. [PDF]

open access: yesSci Rep, 2021
Zhang F   +9 more
europepmc   +1 more source

Reference standards.

open access: yesSouth African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1979
G, Myers, J, Quirk, V, Poplak
openaire   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Designing a set of reference standards for non-targeted analysis of polymer additives extracted from medical devices. [PDF]

open access: yesJ Expo Sci Environ Epidemiol
Yun BH   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy